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Abstract
Stigma is a well-documented barrier to health seeking behavior, engagement in care and adherence to treatment
across a range of health conditions globally. In order to halt the stigmatization process and mitigate the harmful
consequences of health-related stigma (i.e. stigma associated with health conditions), it is critical to have an explicit
theoretical framework to guide intervention development, measurement, research, and policy. Existing stigma frameworks
typically focus on one health condition in isolation and often concentrate on the psychological pathways occurring
among individuals. This tendency has encouraged a siloed approach to research on health-related stigmas, focusing on
individuals, impeding both comparisons across stigmatized conditions and research on innovations to reduce health-
related stigma and improve health outcomes. We propose the Health Stigma and Discrimination Framework, which is a
global, crosscutting framework based on theory, research, and practice, and demonstrate its application to a range of
health conditions, including leprosy, epilepsy, mental health, cancer, HIV, and obesity/overweight. We also discuss how
stigma related to race, gender, sexual orientation, class, and occupation intersects with health-related stigmas,
and examine how the framework can be used to enhance research, programming, and policy efforts. Research and
interventions inspired by a common framework will enable the field to identify similarities and differences in stigma
processes across diseases and will amplify our collective ability to respond effectively and at-scale to a major driver of
poor health outcomes globally.
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Background
Stigma is a well-documented global barrier to health-seek-
ing behavior [1], engagement in care [2], and adherence to
treatment [3] across a range of health conditions [4, 5]. As
a distinguished and labelled difference [6], stigma, Goffman
notes, enables varieties of discrimination that ultimately
deny the individual/group full social acceptance, reduce the
individuals’ opportunities [7], and fuel social inequalities
[8]. Stigma influences population health outcomes by
worsening, undermining, or impeding a number of pro-
cesses, including social relationships, resource availability,
stress, and psychological and behavioral responses, exacer-
bating poor health [9].
In order to intervene to halt the stigmatization process
or mitigate the harmful consequences of health-related
stigma, or stigma associated with health conditions, the
existence of a clear, multi-level theoretical framework to
guide intervention development, measurement, research,
and policy is critical. Existing stigma frameworks typic-
ally focus on one health condition in isolation, for ex-
ample, obesity/overweight [10–17], HIV [8, 18–23], or
mental health [24–28]. This tendency has encouraged a
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siloed approach to research on health-related stigmas,
stifling innovative public health responses. Alderson ar-
gues that it is practical and scientific to examine theor-
ies, as they powerfully influence how evidence is
collected, analysed, understood and used and notes that,
when theories are implicit, their power to clarify or to
confuse, and to reveal or obscure new insights, can work
unnoticed [29]. As such, it is useful to have an explicit
theoretical framework that can both guide research and
intervention development on individual health condi-
tions and allow for comparisons and responses across
health conditions.
The majority of health-related stigma frameworks explore
psychological pathways at the individual level, focusing either
on the individuals experiencing stigma [10, 11, 14–16, 30,
31], those perpetuating stigma [21, 26], or both [20, 24, 32].
While critical to understanding the factors that facilitate and
mediate the stigmatization process for individuals, these
frameworks limit researchers’ ability to inform the
multi-level interventions required to meaningfully influence
the stigmatization process [33]. For some health conditions,
including HIV [8, 18, 19, 23, 34, 35], mental health [27, 28],
child health [35], and obesity/overweight [17], frameworks
addressing the social (e.g. cultural and gender norms) and
structural (e.g. legal environment and health policy) path-
ways leading to stigma, in addition to the individual path-
ways, have been proposed. A few general stigma frameworks
have also highlighted the influence of social and structural
forces on the stigmatization process across socio-ecological
levels [6, 9, 36]. In the context of health-related stigma re-
duction, socio-ecological levels have been defined as public
policy (national and local laws and policies), organizational
(organizations, social institutions, workplaces), community
(cultural values, norms, attitudes), interpersonal (family,
friends, social networks), and individual (knowledge, atti-
tudes, skills) [37].
Building from existing conceptualizations of health-re-
lated stigmas and practical experience in designing
stigma-reduction interventions, we propose a new,
crosscutting framework and demonstrate its application
to a range of health conditions, including leprosy, epi-
lepsy, mental health, cancer, HIV, and obesity/over-
weight. We discuss how stigma related to race, gender,
sexual orientation, class, and occupation intersects with
health-related stigmas, and examine how the framework
can be used to enhance research, programming, and pol-
icy efforts. The framework is intended to amplify our
collective ability to respond effectively and at-scale to a
major driver of poor health outcomes globally.
The Health Stigma and Discrimination Framework
The Health Stigma and Discrimination Framework
(Fig. 1) articulates the stigmatization process as it un-
folds across the socio-ecological spectrum in the context
of health, which can vary across economic contexts in
low-, middle-, and high-income countries. The process
can be broken down into a series of constituent do-
mains, including drivers and facilitators, stigma ‘mark-
ing’, and stigma manifestations, which influence a range
of outcomes among affected populations, as well as or-
ganizations and institutions, that ultimately impact
health and society.
The first domain refers to factors that drive or facili-
tate health-related stigma. Drivers vary by health condi-
tion, but are conceptualized as inherently negative [18].
They may range from fear of infection through casual
contact for communicable diseases and concerns about
productivity due to poor health for chronic conditions,
to authoritarianism and social judgment and blame.
Conversely, facilitators may be positive or negative influ-
ences [33], for example, the presence or absence of oc-
cupational safety standards and protective supplies in
health facilities can minimize or exacerbate stigmatizing
avoidance behaviors towards populations with infectious
diseases by healthcare workers [38]. Drivers and facilita-
tors determine whether stigma ‘marking’ occurs, through
which a stigma is applied to people or groups according
to a specific health condition or other perceived differ-
ence such as race, class, gender, sexual orientation, or
occupation. Intersecting stigma occurs when people are
‘marked’ with multiple stigmas [39]. Once a stigma is ap-
plied, it manifests in a range of stigma experiences (i.e.
lived realities) and practices (i.e. beliefs, attitudes, and
actions). Stigma experiences can include experienced
discrimination, which refers to stigmatizing behaviors
that fall within the purview of the law in some places,
such as refusal of housing [33], and experienced stigma,
or stigmatizing behaviors that fall outside the purview of
the law such as verbal abuse or gossip [33]. The legal
distinction is included as responding to a stigma mani-
festation that is illegal may require a different response
(e.g. litigation) compared with a manifestation that is
not illegal. Another stigma experience is internalized or
‘self-stigma’, which is defined as a stigmatized group
member’s own adoption of negative societal beliefs and
feelings, as well as the social devaluation, associated with
their stigmatized status [40]. Perceived stigma (i.e. per-
ceptions about how stigmatized groups are treated in a
given context) [41] and anticipated stigma (i.e. expecta-
tions of bias being perpetrated by others if their health
condition becomes known) are also classified as stigma
experiences [42]. Finally, secondary or ‘associative’
stigma, which refers to the experience of stigma by fam-
ily or friends of members of stigmatized groups or
among healthcare providers who provide care to mem-
bers of stigmatized groups [43], is included under stigma
experiences. Stigma practices can include stereotypes
(i.e. beliefs about characteristics associated with the
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group and its members), prejudice (i.e. negative evalu-
ation of the group and its members), stigmatizing behav-
ior (i.e. exclusion from social events, avoidance
behaviors, gossip), and discriminatory attitudes (i.e. be-
lief that people with a specific health condition should
not be allowed to participate fully in society). We in-
cluded stereotypes and prejudice under ‘drivers’ and
‘manifestations’, as they both fuel and are reinforced by
the stigmatization process.
We postulate that stigma manifestations subsequently
influence a number of outcomes for affected popula-
tions, including access to justice, access to and accept-
ability of healthcare services, uptake of testing,
adherence to treatment, resilience (i.e. the power to
challenge stigma) [34, 44], and advocacy. They also influ-
ence outcomes for organizations and institutions, in-
cluding laws and policies, the availability and quality of
health services, law enforcement practices, and social
protections.
While the framework is specific to health-related
stigma, it recognizes that health-related stigma often
co-occurs with other, intersecting stigmas, such as those
related to sexual orientation, gender, race, occupation,
and poverty. Therefore, incorporating intersecting stig-
mas into the framework is necessary, as stigma manifes-
tations and health outcomes may be influenced by a
range of stigmatizing circumstances that must be con-
sidered to understand the full impact of stigma [5, 36].
How is the framework different?
The Health Stigma and Discrimination Framework dif-
fers from many other models in that it does not distin-
guish the ‘stigmatized’ from the ‘stigmatizer’ [21, 32].
The absence of this dichotomy is intentional, as we seek
to challenge the ‘us’ versus ‘them’ distinction that en-
ables people to set others apart as ‘different from the
norm’, a key component of the stigmatization process
described by Link and Phelan [6], which precedes stigma
‘marking’. As suggested by Parker and Aggleton [8], we
seek to move away from psychological models that see
stigma as a thing which individuals impose on others
Fig. 1 Health Stigma and Discrimination Framework
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and instead emphasize, the broader social, cultural,
political and economic forces that structure stigma.
According to Kippax et al. [45], the danger in separat-
ing ‘us’ from ‘them’, or ‘agency’ from ‘vulnerability’, is that
it removes the power that vulnerable populations have
to act upon the social contexts driving their experiences,
behaviors, and actions. The dichotomy also leads to an
oversimplified view of vulnerable populations as a group
of individuals defined and connected only by the ‘attri-
bute’ of vulnerability [45]. Our framework seeks to show
the interconnections between power and vulnerability
and how they are fluid and complex. We want to under-
score that all individuals can anticipate, perceive,
internalize, experience, or perpetuate health-related
stigma, while acknowledging unique outcomes for af-
fected populations. There are no clear-cut boundaries
about who experiences and who perpetuates stigma, yet,
as we highlight throughout each example, stigma inter-
sects with other axes of disempowerment and
marginalization (e.g. across race, class, gender) in ways
that result in some persons being more disadvantaged by
health-related stigma. Removing the ‘us’ versus ‘them’ di-
chotomy also makes the framework more palatable to
change agents, such as community leaders, advocates,
and policy-makers, as it highlights that all persons can
act as change agents and underscores the need for
self-reflection and awareness of biases.
Another difference from previous frameworks is the
separation of manifestations into ‘experiences’ and ‘prac-
tices’. This distinction clarifies the pathways to various
outcomes following the stigma-marking phase of the
process. Those who experience, internalize, perceive, or
anticipate health-related stigma face a range of possible
outcomes, such as delayed treatment, poor adherence to
treatment, or intensification of risk behavior, that may di-
minish their health and wellbeing. While outcomes are
mostly negative, positive outcomes are possible; stigma
has been known to foster resilience in marginalized popu-
lations [46] and fuel the formation of patient advocacy
groups and advocacy efforts that have led to major policy
changes to improve access to healthcare for some stigma-
tized conditions like HIV [36, 47]. Stigma practices, on the
other hand, highlight how the stigmatization process can
generate or reinforce stereotypes and prejudice towards
people or groups living with or at risk of various health
conditions and foster discriminatory attitudes that fuel so-
cial inequalities [8].
We also differentiated outcomes for affected popula-
tions (i.e. the stigmatized person or group, as well as
their family, friends, or healthcare providers) from out-
comes for organizations and institutions. Our framework
seeks to demonstrate that stigma experiences and prac-
tices influence affected populations as well as organiza-
tions and institutions, which then together influence the
health and social impacts of stigma. By articulating these
outcomes, the framework highlights the need for multi-
level interventions to respond to health-related stigma.
It also focuses attention on the far-reaching influence of
health-related stigma on societies as well as individuals.
Where to intervene?
Ideally, we want to interrupt the process prior to the ap-
plication of stigma. Thus, interventions often target the
removal of the drivers of stigma or the shifting of norms
and policies that facilitate the stigmatization process
[33]. However, once a stigma is applied to people with a
specific disease or health condition and once it manifests
in experiences or practices, interventions are needed to
mitigate harm and shift harmful attitudes and behaviors
that compromise the general health and wellbeing of af-
fected communities. Stigma-reduction interventions are
most effective when they include components directed
at a range of actors and socio-ecological levels [37]. A
multi-component intervention, for example, may seek to
support individuals with leprosy to cope with experi-
enced stigma and overcome internalized stigma, as well
as reaching out to community members to shift harmful
norms about leprosy through community dialogues or
engaging local leaders to share anti-stigma messages
[48]. Likewise, advocacy with policy-makers and com-
munity leaders about the benefits of syringe exchange
programs to prevent transmission of HIV may be com-
bined with training of law enforcement officers on harm
reduction and proper implementation of laws that
de-criminalize drug use [49].
What to monitor?
The availability of data on health-related stigma and dis-
crimination is critical for improving interventions and
programs to address them, yet such routine data are
often lacking [33]. The Health Stigma and Discrimin-
ation Framework indicates key areas of focus for pro-
gram-, facility-, and national-level monitoring. At the
program level, data on the drivers and facilitators of
stigma are needed to inform appropriate interventions
in a given context. Systematically collected information
regarding the manifestations of stigma is required for re-
searchers and program evaluators to assess the impact
of interventions to reduce stigma or mitigate the related
harmful consequences. Such information is also import-
ant for health facility administrators to identify when
training or changes to institutional policies are required
to ensure a stigma-free healthcare environment. Affected
communities and advocates can use information on stig-
matizing practices, as well as the experiences and real-
ities of affected individuals, to raise awareness among
the general population and policy-makers to facilitate
change. At the national level, data on the outcomes of
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stigma for affected populations and for organizations
and institutions is needed to inform funding for and the
scale of programming to address health-related stigma.
Such information will also help to identify gaps where
new interventions or programs are required.
Why a new framework and how to use it?
Since sociologist Erving Goffman published his seminal
work on stigma in 1963, research on stigma across the
disciplines of sociology, psychology, social science, medi-
cine, and public health have expanded, and much is now
understood about how stigma operates and induces
harm in the context of different diseases and identities.
Yet, progress has stalled in our collective ability to tackle
stigma and its harmful consequences. Therefore,
cross-disciplinary and cross-disease research and collab-
oration are urgently required to move forward.
The Health Stigma and Discrimination Framework is
intended to be a broad, orienting framework, akin to
Pearlin’s Stress Process Model, which was developed to
give some conceptual organization to the diverse lines of
research that were – and still are – underway [50]. It is
our hope that the framework will enable stigma re-
searchers across disciplines to standardize measures,
compare outcomes and build more effective,
cross-cutting interventions. In addition, researchers can
use the framework to generate research foci, to explore
multiple health issues, and consider the interaction be-
tween multiple identities, social inequalities and health
issues. The framework can also point to areas where cli-
nicians, program implementers, and policy-makers can
focus greater attention to better meet the needs of and
improve health outcomes among their clients, communi-
ties, and societies more broadly. Implementation science
approaches can advance how we tailor and apply the
framework to guide stigma and discrimination reduction
interventions and policies, for example, in defining the
target audience for change, what specific drivers and fa-
cilitators of stigma should be addressed, what interven-
tion or policy components are appropriate to address
them, and how to measure change in specific outcomes
overtime.
Practical applications
To demonstrate the cross-cutting nature of the Health
Stigma and Discrimination Framework, we examine how
it applies to both communicable and non-communicable
health conditions. We review health conditions in roughly
chronological order to provide perspective on how
health-related stigma has been applied to new and emer-
ging conditions throughout the course of human history.
While the different domains of stigma articulated in the
framework may not apply in the exact same way across all
health conditions, health-related stigmas share a number
of commonalities that warrant underscoring.
Firstly, social exclusion rooted in stigma appears to be
a response to threat, varying across health-related stigma
to the degree to which the source of threat is physical
(such as fear of biological contagion, fear of violence and
harm) or symbolic (such as aversion based on percep-
tions that the person does not adhere to central cultural
values). Across the various health-related stigmas, people
negatively stereotype, display prejudice toward, and dis-
criminate the group and its members, although the con-
tent of the stereotype (e.g. being promiscuous, unclean)
and the rationalization for the bias differ across the
groups. In addition, these conditions differ in the extent
to which they are concealable and thus in the way
people cope with and manage their stigmatized identity,
but all involve anticipated, experienced, and internalized
stigma. Finally, how people cope with and manage
stigma often adversely affects their health, both in terms
of the stress it causes and in the underutilization of ser-
vices available to them. Table 1 highlights both the com-
monalties and differences in drivers, facilitators,
intersecting stigmas, manifestations, outcomes, and im-
pacts relevant to leprosy, epilepsy, mental health, cancer,
HIV, and obesity/overweight, which are further explored
below.
Leprosy
Leprosy is perhaps the oldest stigmatized health condi-
tion known to humankind [51]. Most major religious
scriptures make mention of leprosy, often as a condition
to be avoided and/or as a divine supernatural punish-
ment for sin or breaking a taboo [52]. The notion that
leprosy – or a group of skin diseases that included lep-
rosy – was contagious was already present in the Old
Testament of the Bible. Fear of contagion and social ex-
clusion remains closely tied to the image of leprosy [53–
55] and the belief that leprosy is hereditary is also wide-
spread [54, 56]. Together, these factors drive the
stigmatization process for people living with leprosy.
The fact that persons affected by leprosy often have a
low socioeconomic status, a low level of education and
little awareness of human rights increases people’s vul-
nerability to discrimination [57]. In South Asia, a
low-caste background can add a further, intersecting
layer of stigma, as is the case for women in many en-
demic countries [58]. The stigma attached to leprosy
typically manifests as a ‘spoiled identity’ in the affected
person, affecting status and reputation, including that of
family members [54, 59]. Social participation may be se-
verely restricted, including problems in finding or main-
taining a job, reduced access to education, reduced
opportunities in finding a marital partner or problems in
ongoing marriages, and sexual health [52, 60–62].
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Further, many persons affected seek to conceal their
condition [63, 64]. Concealment causes stress and anx-
iety, but may also lead to a delay in presenting for diag-
nosis and treatment [65, 66]. When treatment is delayed,
the severity of disability may increase [67, 68]. Others
may opt to discontinue treatment rather than risk ‘being
found out’ [64]. At the personal level, these outcomes of
stigma lead to a number of negative impacts for people
living with leprosy, such as reduced quality of life and
mental wellbeing, including a much increased risk of
anxiety and depression [69, 70]. At the organizational
level, leprosy-related stigma outcomes may include poor
quality of health services and increased staff turnover.
At the societal level, the combined impact of these out-
comes may be prolonged transmission of bacilli in the
community.
Epilepsy
Epilepsy is a neurological condition characterized by
chronic or recurrent seizures. Seizures can lead to indi-
viduals crying out, collapsing, bleeding or foaming from
the mouth, and losing control of urine and/or stools,
and can therefore be frightening to those experiencing
or witnessing them. Epilepsy is both concealable and un-
predictable – it may be impossible to know that some-
one has epilepsy until they experience a seizure and it
may be impossible to predict the onset of a seizure.
Epilepsy-related stigma is largely driven by concerns
about productivity and longevity, and fear of infection.
Members of the general public endorse beliefs that
people with epilepsy cannot contribute meaningfully to
society and are poor prospects for marriage and employ-
ment [71–73]. Moreover, despite epilepsy not being con-
tagious, some believe that epilepsy is contagious through
saliva [74]. Such fears of contagion may be particularly
problematic when they are endorsed by first responders,
including police officers [75].
Religious and supernatural beliefs act as facilitators of
epilepsy-related stigma in some contexts, with some be-
lieving that epilepsy is a curse or caused by witchcraft
[76]. Risk factors for epilepsy include other health issues
(e.g. cerebral palsy, birth asphyxia, stroke) and injuries
(e.g. traumatic brain injury), and therefore epilepsy-related
stigma may intersect with these other health-related stig-
mas. People with epilepsy experience a number of mani-
festations, such as social rejection and exclusion in a
range of contexts, including familial and romantic [77].
Children with epilepsy have lower educational achieve-
ment and adults with epilepsy experience discrimination
within the workplace [76]. Adults with uncontrolled sei-
zures are less likely to be employed and more likely to re-
port job problems when employed [77]. Outcomes of
epilepsy-related stigma include lower self-efficacy sur-
rounding treatment engagement and lower medication
adherence [4]. Institutional outcomes include stigmatizing
policies such as driving and/or employment restrictions
that may be disproportionate to illness severity [78].
Epilepsy-related stigma ultimately undermines the quality
of life of people living with epilepsy [72].
Mental health
Mental health-related stigma is often grounded in ste-
reotypes that persons with mental health issues are dan-
gerous (unpredictable, violent), responsible for their
mental health issue, cannot be controlled nor recover,
and should be ashamed [79]. Persons with mental health
issues are often viewed as incompetent and unable to
work or live independently [79]. Negative public atti-
tudes, opinions, and intentions persist and are reported
across diverse global contexts [80–83]. For instance,
findings from the Stigma in Global Context – Mental
Health Study, examining responses to scenarios of de-
pression and schizophrenia in 16 countries [84], indi-
cated that core ‘backbone’ stigmatizing beliefs remain
across settings with regards to having a person with
mental health issues provide childcare, teach children,
marry into the family, attempt self-harm, or hold author-
ity positions.
Race and gender appear to intersect with mental
health-related stigma, influencing its severity. For ex-
ample, a higher risk for psychiatric disorders among
Caribbean-born versus US-born black men has been re-
ported [85] and greater embarrassment in seeking mental
health care has been reported among Somalian-born par-
ticipants compared to US-born black participants [86].
Certain mental health concerns are perceived as mascu-
line (e.g. addiction, antisocial personality disorder) and
others as feminine (e.g. eating disorder), and public stigma
towards issues perceived as masculine appears to be
higher than towards those perceived as feminine [87, 88].
There are also gender differences in perceived stigma,
where men may experience elevated stress regarding dis-
closing mental health issues in comparison to women
[89]. Anticipated and perceived stigma are common mani-
festations of mental health-related stigma, contributing to
fear of acknowledging one’s mental health issue and pos-
sibly leading to shame and avoidance regarding seeking
mental health care [90, 91]. Mental health-related stigma
also has a profound influence on life opportunities and
persons realizing their goals and potential; it is associated
with lower self-efficacy and self-esteem and compromised
engagement in employment and independent living [92].
Public policy responses in some countries have gone a
long way towards reducing or ameliorating the harmful
effects of mental health-related stigma at the
organizational and institutional levels. For example, in
the US, the Americans with Disabilities Act [93] enacted
in 1990 called for preventing discrimination on the basis
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of mental health and for the social inclusion and partici-
pation of persons with mental health issues in society. In
1999, this was followed by Mental Health: A Report of
the Surgeon General [94] to inform the public of mental
health issues and raise awareness of stigma and discrim-
ination. Additionally, California’s Mental Health Services
Act in 2004 [95] addressed stigma at institutional, soci-
etal and individual levels, including social marketing,
training, and a focus on cultural competence.
Cancer
Cancer encompasses a large group of diseases character-
ized by the uncontrolled growth and spread of abnormal
cells. Despite the fact that many cancers can be cured or
at least effectively controlled, it remains a highly stigma-
tized condition, with some types of cancer more stigma-
tized than others [96]. One key factor in the
stigmatization of different types of cancer involves per-
ceptions of the individual’s responsibility for having the
disease. For example, cancers of the lung are highly stig-
matized [1] due to the belief that smoking is their pri-
mary cause, which is believed to be under the person’s
control [97]. Most people have negative explicit and im-
plicit attitudes toward smoking and those who smoke
[98], which may further strengthen the stigmatization of
people with lung cancer. A second factor underlying
cancer-related stigma is the degree to which the disease
causes apparent disfigurement such as cancers of the
throat or mouth. As with other physical conditions, such
as weight loss/gain or leprosy, the physical abnormalities
associated with some forms of cancer activate the behav-
ioral immune system, eliciting negative emotions such as
disgust or aversion, distancing, and avoidance [99].
The experience of cancer-related stigma has important
psychological, physical, and social consequences. Psycho-
logically, it is associated with depression, anxiety, and
demoralization among patients with cancer [100]. Indi-
viduals who experience greater cancer-related stigma
tend to delay more in seeking medical care [101] and
often attempt to conceal their disease from others [102].
To the extent to which people experience stigma and
shame associated with their disease, such as is common
with people with lung cancer, they often experience dis-
ruption in their personal relationships and decreased
marital satisfaction, as well as increased depression, par-
ticularly when they blame themselves for their illness
[103]. Greater internalization of cancer-related stigma
leads to lower self-esteem and poorer mental health,
smaller social networks and less opportunity to receive
social support, and greater anticipated social rejection,
all of which compromise the quality of life [104].
The stigma associated with cancer varies across reli-
gions and related cultures. Although women who are
members of ultra-Orthodox Jewish communities are at
heightened risk for both breast and ovarian cancer due
to an increased probability of being carriers of certain
genes associated with these cancers given their Eastern
and Central European ancestry, they tend to have low
screening rates, low health literacy, and poor health
practices because of the stigmatization of cancer in these
communities [105]. Fears that a diagnosis of breast can-
cer will dim prospects for arranged marriages have been
shown to discourage single Muslim women from acces-
sing treatment for breast cancer in Pakistan [106]. Simi-
larly, South Asian immigrant women of many different
faiths in Canada share the belief that having a breast
cancer diagnosis would threaten a family’s social status
and lead to spousal rejection [106].
HIV
HIV is a potentially life-threatening disease caused by a
virus that weakens the immune system and spreads
through blood and sexual contact. HIV-related stigma is
driven by several factors, including (1) fear of infection,
where people living with HIV (PLHIV) may be perceived
as threatening due to the infectious nature of HIV; (2)
concerns about productivity and longevity, where PLHIV
may be perceived as poor prospects for employment,
friendships, and romantic relationships; and (3) social
norm enforcement, since HIV risk is related to a range
of socially stigmatized behaviors (e.g. same-sex sexual re-
lations, injection drug use, sex work) and therefore
PLHIV are devalued due to their perceived associations
with these behaviors [107, 108]. Factors that facilitate
HIV stigma range from laws that criminalize HIV trans-
mission or specific professions (e.g. sex work) or behav-
iors (e.g. same-sex sexual relations, injection drug use)
to the lack of universal protection supplies in health fa-
cilities. Key populations for HIV include men who have
sex with men, people with histories of injection drug
use, racial and ethnic minorities, and sex workers, and
therefore stigmas that intersect with HIV include those
associated with sexual orientation, substance use, race,
and occupation [36, 109].
PLHIV, including adolescents and young people, report
a range of stigmatizing experiences from others, including
social rejection, exclusion, gossip, and poor healthcare,
and are at risk of internalizing stigma [110]. The level of
HIV stigma in communities and societies influences a
number of stigma practices, such as discriminatory atti-
tudes among the general public and healthcare workers,
and harmful stereotypes and prejudices that can lead to
stigmatizing behavior towards PLHIV (exclusion, verbal
abuse, etc.). Outcomes of HIV stigma for people at risk of
or living with HIV include engagement in greater HIV risk
behaviors, lower rates of HIV testing, worse engagement
and retention in HIV care, and worse initiation and adher-
ence to medication [3, 44, 111]. Institutional outcomes
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include stigmatizing policies such as those that criminalize
PLHIV who do not disclose their HIV status to their part-
ners or prohibit PLHIV from traveling. Finally,
HIV-related stigma has downstream effects on HIV inci-
dence as well as morbidity, mortality, and quality of life
for PLHIV [3, 109].
Overweight and obesity
The stigma associated with weight is particularly strong,
pervasive, and openly expressed. There seem to be min-
imal social norms prohibiting weight shaming, making it
particularly problematic. It develops relatively early in
socialization, emerging as early as 31 months [112].
Obesity and overweight are often perceived as culturally
non-normative, and therefore people with obesity or
overweight are often perceived unfavorably, negatively
stereotyped, and discriminated against. Additionally,
since weight is generally perceived as personally control-
lable, overweight implies negative personal qualities. In-
dividuals with obesity are often blamed for their weight
status and stereotyped as lazy, lacking willpower, incom-
petent, and unattractive, particularly in cultures that
hold core values, such as the Protestant Work Ethic, that
emphasize self-control and hard work [113]. In addition
to concerns about character, because obesity and over-
weight are perceived as abnormal physical features, they
may activate the behavioral immune system [99] and
elicit disgust and related concerns about disease avoid-
ance [114], which leads to distancing and other direct
forms of social rejection. Weight-based disparities are
well documented in employment, healthcare, education,
and interpersonal outcomes [115, 116].
Experiencing and anticipating weight-based stigma (in-
cluding discrimination, teasing and bullying, social rejec-
tion, and other forms of unfair treatment) adversely
affects the mental and physical health of people with
overweight or obesity [117]. Psychologically, experien-
cing greater weight-based discrimination is associated
with heightened distress (including depression and anx-
iety) and low self-esteem generally, as well as
demoralization and diminished confidence in being able
to pursue health-promoting behaviors. Physically, people
who experience greater weight-based stigma display less
cardiovascular fitness, muscular strength, and endurance
[118]. Further, since exposure to weight-based stigma
generally reduces motivation, intentions, and feelings of
efficacy related to engaging in health-promoting behav-
iors, weight-based stigma has adverse effects on weight
management. Consequently, experiencing more
weight-based stigmatization predicts greater caloric con-
sumption and reduced energy expenditure during
weight-loss treatment [119]. Thus, weight stigma may
contribute to obesity-related health problems due to
added stress and reduced engagement in health-
promoting behaviors, which jointly operate to increase
or maintain excess weight.
In healthcare settings, women who perceive
stigmatization from their providers report delaying use of
preventive health services for fear of being judged or
embarrassed [120]. This avoidance of care allows for un-
treated problems to progress to a more advanced stage
that may be more difficult to treat, thus exacerbating
health problems. Moreover, these psychological, physical,
motivational, and behavioral effects of weight-based
stigma are particularly strong among individuals who
internalize this stigma to a greater degree. In terms of re-
sponses at the public policy level, there are currently no
federal laws against weight-based discrimination; however,
one state (Michigan), and a limited number of cities in the
US, legally prohibit weight-based discrimination.
Discussion
The Health Stigma and Discrimination Framework pro-
vides an innovative and alternative method to
conceptualize and respond to health-related stigmas.
Applicable across a range of health conditions and dis-
eases, the framework highlights the domains and path-
ways common across health-related stigmas and
suggests key areas for research, intervention, monitoring,
and policy. This crosscutting approach will support a
more efficient and effective response to addressing a sig-
nificant source of poor health outcomes globally.
The Health Stigma and Discrimination Framework has
practical applications for program implementers,
policy-makers, and researchers alike, providing a ‘com-
mon ground’ to inform discourse around research prior-
ities, developing innovative responses and implementing
them at scale. For program implementers, the frame-
work can inform the combination and level of interven-
tions most appropriate for responding to a specific type
of health-related stigma. For policy-makers, the frame-
work has the potential to lead to efficiencies in funding
for and implementation of efforts to reduce
health-related stigmas. Lastly, for researchers, the frame-
work should enable more concise and comparable mea-
sures of stigma that can be compared across health
conditions and diseases by removing the disease siloes of
the past and replacing them with common domains and
terminology that is more accessible. The framework
should also enable crosscutting research endeavors to
develop and test interventions that more appropriately
address the lived realities of vulnerable populations
accessing healthcare systems.
People are not defined by just one disease or one per-
ceived difference, they have complex realities in which
to maneuver in order to protect their health and well-
being, and public health interventions must be respon-
sive to these realities.
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